Patents for C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203) |
---|
04/25/2002 | CA2426487A1 Ep4 receptor inhibitors to treat rheumatoid arthritis |
04/25/2002 | CA2423792A1 Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists |
04/24/2002 | EP0714299B1 Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists |
04/24/2002 | CN1346355A Novel inhibitors of farnesyl-protein transferase |
04/24/2002 | CN1346351A 1,2-benzothiazepines for the treatment of hyperlipidemic diseases |
04/24/2002 | CN1346350A Compound which inhibiti leukocyte adhesion mediated by VLA-4 |
04/24/2002 | CN1346271A Quinazoline derivatives as angiogenesis inhibitors |
04/23/2002 | US6376672 Restenosis; vision defects; cardiovascular disorders; kidney dieases |
04/23/2002 | US6376526 For huans, animals |
04/23/2002 | US6376515 Benzamides and related inhibitors of factor Xa |
04/23/2002 | US6376497 Excellent, wide-spectrum antifungal activities and low toxicity |
04/23/2002 | US6376490 Strong n-methyl-d-asparate receptor antagonists; useful in treating strokes, ischemia, and central nervous system injuries |
04/23/2002 | US6376429 Controlling weeds |
04/23/2002 | US6376428 Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production |
04/18/2002 | WO2002030921A1 Herbicidally active pyridine sulfonyl urea derivatives |
04/18/2002 | WO2002030908A1 Inhibitors of protein kinases |
04/18/2002 | WO2002030881A1 Sulfonylguanidine |
04/18/2002 | US20020045762 Process for preparing 1-guanylpyrazole acid adducts |
04/18/2002 | DE10048716A1 Use of sulfonylguanidine derivatives, mostly new compounds, for treating e.g. pain and neurodegeneration, have affinity for the gabapentin binding site |
04/18/2002 | DE10046934A1 Verfahren zur fermentativen Herstellung von nicht-proteinogenen L-Aminosäuren A process for the fermentative production of non-proteinogenic L-amino acids |
04/18/2002 | CA2424107A1 Sulfonylguanidines |
04/18/2002 | CA2394084A1 Inhibitors of protein kinases |
04/17/2002 | EP1197486A1 Process for the preparation of 1H-pyrazole-1-carboxamidines |
04/17/2002 | EP1196411A1 Bradykinin b1 receptor antagonists |
04/17/2002 | EP1196397A1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
04/17/2002 | EP1196384A1 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof |
04/17/2002 | CN1345308A Acetylenic alpha-amino acid based sulfonamide hydroxamic acid TACE inhibitors |
04/17/2002 | CN1344801A Method for production of non-proteinogen L-amino acid by fermentation |
04/17/2002 | CN1082953C Process to prepare oxazolidinones |
04/16/2002 | US6372767 Benzanilides as potassium channel openers |
04/16/2002 | US6372736 Heterocyclic compounds as inhibitors of rotamase enzymes |
04/16/2002 | US6372682 Contacting one or more olefin monomers with a group 8-10 transition metal complex catalyst and optionally a bronsted or lewis acid |
04/16/2002 | CA2218552C Benzimidazole compounds and their use as modulators of the gabaa receptor complex |
04/16/2002 | CA2217601C Benzimidazole compounds and their use as modulators of the gabaa receptor complex |
04/11/2002 | WO2002028839A1 Benzimidazole and indole derivatives as crf receptor modulators |
04/11/2002 | WO2002028810A2 Retinoids for the treatment of emphysema |
04/11/2002 | US20020042414 Antiallergens |
04/11/2002 | US20020042410 Central nervous system disorders therapy |
04/11/2002 | CA2425185A1 Benzimidazole and indole derivatives as crf receptor modulators |
04/10/2002 | EP1195376A1 Azoamidine compounds and their use as polymerization initiators |
04/10/2002 | EP1194410A1 Benzimidazole derivatives and pharmaceutical compositions comprising these compounds |
04/10/2002 | EP1194227A1 Preparation and use of ionic liquids in microwave-assisted chemical transformations |
04/10/2002 | EP0739338B1 serine protease inhibitors: derivatives of isothiazolidin-3-one-1,1 dioxide and 3-oxo-1,2,5-thiadiazolidine-1,1-dioxide |
04/10/2002 | CN1344254A Quinoline derivatives and quinazoline derivatives |
04/10/2002 | CN1082503C Method of preparing alpha-methoxyiminocarboxylic acid methylamides, and intermediates used in said method |
04/09/2002 | US6369086 Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors |
04/04/2002 | WO2002026727A2 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
04/04/2002 | WO2001064643A3 Benzamides and related inhibitors of factor xa |
04/04/2002 | US20020040147 Novel catechols as antimicrobial agents |
04/04/2002 | US20020040061 Compounds such as 1-(3-(2-hydroxybenzoylamino)propyl)-2-pyrrolidinone; dosage forms of bioactive agents or drugs |
04/04/2002 | US20020040040 N-(3,5-bis-trifluoromethyl-benzyl)-6-(4-hydroxyacetyl-piperazin-1 -yl)-N-methyl-4-o-tolyl-nicotinamide, for example |
04/04/2002 | US20020040024 A phenoxy substituted piperidine derivative, useful for treating or preventing histamine H3 receptor activity |
04/04/2002 | US20020039767 Batch processing using nucleophilic compound |
04/04/2002 | DE10044792A1 Substituierte Phenylcyclohexancarbonsäureamide und ihre Verwendung Substituted Phenylcyclohexancarbonsäureamide and their use |
04/04/2002 | CA2423919A1 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
04/03/2002 | EP1193259A1 Dihydropyrimidine derivatives |
04/03/2002 | EP1193250A1 Phenyl sulfamate derivatives |
04/03/2002 | EP1192145A1 Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines |
04/03/2002 | EP1162201A9 Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives |
04/03/2002 | EP0865440B1 Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives |
04/03/2002 | CN1082050C Azole cojpounds endowed with antimycotic activity for human and veterinary use |
04/02/2002 | US6365736 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals |
04/02/2002 | US6365588 Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
04/02/2002 | US6365301 Delocalized nitrogen, oxygen, sulfur or phoshorous onium cation; bis-fluorosulfonimidide anion or bis-difluorophos-phonylamidide anion |
03/28/2002 | WO2002024693A1 A process for producing 3,4-dihydro naphthyridinone analogs |
03/28/2002 | WO2002024687A1 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinolinone derivatives |
03/28/2002 | WO2002024686A2 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives |
03/28/2002 | WO2002024685A1 Indole derivatives and their use as antifungal and/or antiparasitic agents |
03/28/2002 | WO2002024682A1 Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors |
03/28/2002 | WO2002024679A1 PYRIDINE DERIVATIVES WITH IKB-KINASE (IKK-β) INHIBITING ACTIVITY |
03/28/2002 | WO2002024666A2 4-amino-quinazolines |
03/28/2002 | WO2002024651A1 A process for producing 2-amino-4,6-disubstituted nicotinic acid ester analogs |
03/28/2002 | WO2002024200A1 Substituted azole derivatives as inhibitors of corticotropin releasing factor |
03/28/2002 | WO2001083434A3 P-(sulfonyl)-aryl and heteroaryls amines |
03/28/2002 | US20020038059 Purification of alkenyl compounds |
03/28/2002 | US20020038030 For therapy of inflammatory conditions including migraine, rheumatoid arthritis, asthma, and inflammatory bowel disease as well as mediation of the emetic reflex and the modulation of central nervous system (CNS) disorders such as Parkinson's |
03/28/2002 | US20020037907 Substituted 2- (S) -hydroxy-3- (piperidin-4-yl-methylamino) -propyl ethers and substituted 2-aryl-2- (R) - hydroxy-1- (piperidin-4-yl-methyl) -ethylamine beta-3 adrenergic receptor agonists |
03/28/2002 | US20020037896 Bicyclic compounds |
03/28/2002 | US20020037888 4-imidazol-1-ylmethyl-2-(2-(2-oxo-piperidin-1-yl)-phenoxy) -benzonitrile for example; farnesyl-protein transferase inhibitors; treating cancer, benign proliferative disorder, hepatitis virus, restenosis, and polycystic kidney disease |
03/28/2002 | US20020037324 Aqueous solubility pharmaceutical formulations |
03/28/2002 | CA2423156A1 Substituted azole derivatives as inhibitors of corticotropin releasing factor |
03/28/2002 | CA2423151A1 Indole derivatives and their use as antifungal and/or antiparasitic agents |
03/28/2002 | CA2422923A1 Pyridine derivatives with ikb-kinase (ikk-.beta.) inhibiting activity |
03/28/2002 | CA2422560A1 4-amino-quinazolines |
03/27/2002 | EP1191106A1 Verfahren zur fermentativen Herstellung von nicht-proteinogenen L-Aminosäuren |
03/27/2002 | EP1189879A1 INHIBITORS OF FACTOR Xa |
03/27/2002 | EP1189609A1 Cxcr-4 receptor antagonists - thrombopoietin mimetics |
03/27/2002 | CN1342145A Fused-ring compounds and use thereof as drugs |
03/27/2002 | CN1081625C 1-aryl-2-acylamino-ethane compounds and their use as meurokinin especially neurokinin 1 antagonists |
03/26/2002 | US6362373 Chiral amino alcohols and process for preparation of same |
03/26/2002 | US6362334 Phthalamide compounds |
03/26/2002 | US6362206 Azole compounds, their production and use |
03/26/2002 | US6362189 Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
03/26/2002 | US6362188 Farnesyl protein transferase inhibitors |
03/26/2002 | US6362134 Controlling plant growth |
03/26/2002 | US6361920 Photographic material containing a novel hydrazide type |
03/26/2002 | CA2032498C Novel 8-substituted-2-aminotetralines |
03/21/2002 | WO2002022608A1 Pyrazole compounds useful as protein kinase inhibitors |
03/21/2002 | WO2002022607A1 Pyrazole compounds useful as protein kinase inhibitors |
03/21/2002 | WO2002022606A1 Pyrazole compounds useful as protein kinase inhibitors |